Sung-Woo Lee 1,2,8, Ju Sik Yun 3,8, Young Ju Kim 1,2,4,5, Saei Jeong 1,2,4,5, Jeong Eun Noh 1,2,4,5, Hee-Ok Kim 6, Hyun-Ju Cho 7, Cheol-Kyu Park 7, In-Jae Oh 7,* and Jae-Ho Cho 1,2,4,5,*
1Department of Microbiology and Immunology, Chonnam National University Medical School, Gwangju, Republic of Korea.
2Medical Research Center for Combinatorial Tumor Immunotherapy, Chonnam National University Medical School, Gwangju, Republic of Korea.
3Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School, Hwasun Hospital, Gwangju, Republic of Korea.
4National Immunotherapy Innovation Center, Chonnam National University Medical School, Gwangju, Republic of Korea.
5BioMedical Sciences Graduate Program, Chonnam National University Medical School, Gwangju, Republic of Korea.
6Selecxine Inc., Seoul, Republic of Korea.
7Department of Internal Medicine, Chonnam National University Medical School, Hwasun Hospital, Gwangju, Republic of Korea.
8These authors contributed equally: Sung-Woo Lee, Ju Sik Yun.
*Corresponding authors: correspondence to In-Jae Oh or Jae-Ho Cho